CAS 14365-45-8
:2'-DESOXY-B-L-ADENOSIN
- 9-(2-deoxy-beta-L-threo-pentofuranosyl)-9H-purin-6-amine
(2S,3R,5R)-5-(6-Amino-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol
CAS:Formel:C10H13N5O3Reinheit:98%Farbe und Form:SolidMolekulargewicht:251.24199-(2-Deoxy-β-L-Ribofuranosyl)Adenine
CAS:9-(2-Deoxy-β-L-Ribofuranosyl)AdenineReinheit:98%Molekulargewicht:251.24g/mol2'-Deoxy-beta-L-adenosine
CAS:Kontrolliertes ProduktApplications A useful synthon for modified oligodeoxyribonucleotides.
References Fujimori, S., et al.: Nucleoside & Nucleotide, 11(2-4), 341 (1992)Formel:C10H13N5O3Farbe und Form:NeatMolekulargewicht:251.242’-Deoxy-β-L-adenosine (May contain up to 20% inorganics)
CAS:Kontrolliertes ProduktFormel:C10H13N5O3Farbe und Form:NeatMolekulargewicht:251.242'-Deoxy-L-adenosine
CAS:2'-Deoxy-L-adenosine is an adenosine analogue that has been shown to inhibit the growth of tumor cells in mice. The mechanism of this inhibition is not well understood, but it is thought that 2'-deoxy-L-adenosine inhibits the adenosine A3 receptor and blocks the activation of toll-like receptors. This drug also has been shown to have anti-inflammatory properties, which may be due to its ability to inhibit prostaglandin synthesis. It has been used as a model system for studying cellular responses to DNA damage caused by ultraviolet radiation. 2'-Deoxy-L-adenosine also has been shown to have a cytotoxic effect on human HL60 cells, which is mediated by nuclear DNA fragmentation.
Formel:C10H13N5O3Reinheit:Min. 98 Area-%Farbe und Form:Off-White PowderMolekulargewicht:251.25 g/molRef: 3D-ND04246
Ausgelaufenes produkt





